Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Announces It Will Buy Back $11 Billion in Shares
Bloomberg
Thursday, October 23, 2014 - 5:26pm
tags:
Pfizer, share repurchase
GSK restructures, as respiratory disappoints
Medical Marketing and Media
Thursday, October 23, 2014 - 9:52am
tags:
GSK
Celgene 3rd-quarter profit jumps 37 pct, tops forecast
Yahoo/Reuters
Thursday, October 23, 2014 - 9:39am
tags:
Celgene, earnings
Alexion Pharma quarterly adj profit beats, raises forecast again
Yahoo/Reuters
Thursday, October 23, 2014 - 9:38am
tags:
Alexion, earnings
CR Bard Beats Q3 Earnings and Revenues, '14 View Raised
Yahoo/Zacks.com
Thursday, October 23, 2014 - 9:37am
tags:
CR Bard, earnings, devices
Boehringer revs up Ofev sales force, support services to rival Roche's Esbriet in IPF
Fierce Pharma Marketing
Thursday, October 23, 2014 - 8:41am
tags:
Boehringer Ingelheim, drug reps, Ofev, Roche, Esbriet, IPF
Novartis Announces Positive Phase-III Results For Secukinumab
Bidness Etc.
Thursday, October 23, 2014 - 8:38am
tags:
Novartis, secukinumab, ankylosing spondylitis
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
Yahoo
Thursday, October 23, 2014 - 8:36am
tags:
Takeda, Sucampo, Amitiza
Pfizer Wins SUTENT® Patent Case In Delaware District Court
Yahoo
Thursday, October 23, 2014 - 8:34am
tags:
Pfizer, patents, Sutent, Delaware
Boston Scientific Turnaround Complete, CEO Mahoney Says
Bloomberg
Thursday, October 23, 2014 - 8:11am
tags:
Boston Scientific, devices
Drugmakers may need indemnity for fast-tracked Ebola vaccines
Yahoo/Reuters
Thursday, October 23, 2014 - 8:08am
tags:
ebola virus, FDA, fast track, vaccines
Lilly Misses Estimates as Patent Expirations Cut Sales
Bloomberg
Thursday, October 23, 2014 - 8:02am
tags:
Eli Lilly, earnings
The Mylan-Abbott Inversion Deal is Still on… but With Some Changes
WSJ Pharmalot
Wednesday, October 22, 2014 - 7:14pm
tags:
Mylan Labs, Abbott Labs, M&A, tax inversions
Hemispherx Joins The Ebola Game
Yahoo/Benzinga
Wednesday, October 22, 2014 - 7:11pm
tags:
Hemispherx Biopharma, ebola virus
Regulus Therapeutics more than doubles on early data for microRNA treatment for hepatitis C
Yahoo/AP
Wednesday, October 22, 2014 - 7:05pm
tags:
Regulus, hepatitis C, microRNA, RG-101
Eli Lilly adds $375M to Zymeworks partnership
Yahoo/AP
Wednesday, October 22, 2014 - 7:00pm
tags:
Eli Lilly, Zymeworks, cancer immunotherapy
AbbVie finally admits it was trying to dodge U.S. taxes
Fortune
Wednesday, October 22, 2014 - 6:57pm
tags:
AbbVie, Shire, tax inversions, M&A
Roche blueprints a $1.8B R&D complex for pRED
Fierce Biotech
Wednesday, October 22, 2014 - 9:56am
tags:
Roche, R&D, pRED
Biogen drops after disclosure of Tecfidera patient death
Seeking Alpha
Wednesday, October 22, 2014 - 9:55am
tags:
Biogen Idec, Tecfidera
Intuitive Surgical Q3 Earnings Fall but Beat Estimates
Yahoo/Zacks.com
Wednesday, October 22, 2014 - 9:52am
tags:
Intuitive Surgical, earnings, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.